Nurix Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $355.6M
Liabilities Breakdown FY2023
Total Liabilities: $155.1M
Asset Breakdown
Total Assets: $355.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $54.6M | 15.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $16.8M | 4.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $284.2M | 79.9% |
Liabilities Breakdown
Total Liabilities: $155.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $6.4M | 4.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $148.7M | 95.9% |